JPWO2025070707A1 - - Google Patents

Info

Publication number
JPWO2025070707A1
JPWO2025070707A1 JP2025549163A JP2025549163A JPWO2025070707A1 JP WO2025070707 A1 JPWO2025070707 A1 JP WO2025070707A1 JP 2025549163 A JP2025549163 A JP 2025549163A JP 2025549163 A JP2025549163 A JP 2025549163A JP WO2025070707 A1 JPWO2025070707 A1 JP WO2025070707A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025549163A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025070707A1 publication Critical patent/JPWO2025070707A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2025549163A 2023-09-29 2024-09-27 Pending JPWO2025070707A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023170359 2023-09-29
PCT/JP2024/034608 WO2025070707A1 (ja) 2023-09-29 2024-09-27 フレイルを予防、又は改善するためのジアミン、及び/又はポリアミンを含む組成物

Publications (1)

Publication Number Publication Date
JPWO2025070707A1 true JPWO2025070707A1 (cg-RX-API-DMAC7.html) 2025-04-03

Family

ID=95201699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025549163A Pending JPWO2025070707A1 (cg-RX-API-DMAC7.html) 2023-09-29 2024-09-27

Country Status (2)

Country Link
JP (1) JPWO2025070707A1 (cg-RX-API-DMAC7.html)
WO (1) WO2025070707A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3086250A1 (en) * 2017-12-20 2019-06-27 Societe Des Produits Nestle S.A. Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagy
US20220296550A1 (en) * 2019-06-20 2022-09-22 Societe Des Produits Nestle S.A. Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids
EP4213821A2 (en) * 2020-09-21 2023-07-26 The Regents of the University of California Immunological effects of metabolites
US20250228796A1 (en) * 2022-03-22 2025-07-17 Sato Pharmaceutical Co., Ltd. Skeletal muscle enhancer

Also Published As

Publication number Publication date
WO2025070707A1 (ja) 2025-04-03